3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Conditions
Pancreatic Neoplasms
34
Carcinoma, Non-Small-Cell Lung
25
Breast Neoplasms
15
Lung Neoplasms
13
Neoplasm Metastasis
12
Triple Negative Breast Neoplasms
11
Neoplasms
9
Colorectal Neoplasms
8
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Carcinoma, Pancreatic Ductal
4
Stomach Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Head and Neck Neoplasms
3
Gastrointestinal Neoplasms
3
Adenocarcinoma
3
Rectal Neoplasms
2
Ovarian Neoplasms
2
Neoplasms by Site
2
Gallbladder Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Carcinoma
2
Brain Neoplasms
2
Vaccinia
1
Thyroid Neoplasms
1
Thymoma
1
Thymic epithelial tumor
1
Thoracic Neoplasms
1
Interventions
Bevacizumab
3
contrast agent BR1
2
pralsetinib
1
pembrolizumab
1
Pemetrexed
1
Paclitaxel
1
Microbubbles
1
Gemcitabine
1
Cisplatin
1
Carboplatin
1
Biopsy
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Nerve Tissue
×
130-nm albumin-bound paclitaxel
×
90 days
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts